Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

9.75
+0.06000.62%
Post-market: 9.770.0155+0.16%19:42 EDT
Volume:11.78M
Turnover:114.52M
Market Cap:10.33B
PE:-9.86
High:9.93
Open:9.50
Low:9.33
Close:9.69
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:0.56
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-9.87
PE(LYR):-25.52

Loading ...

Oct 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2026

Major Issues Report

Form 8-K - Current report
Jun 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 09, 2026

Major Issues Report

Form 8-K - Current report
Apr 06, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Feb 24, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2026

Proposed Sale Of Securities

Form 144 | ImmunityBio Director Christobel Selecky proposes to sell 25,000 shares, with a total value of approximately $217,500
Feb 23, 2026

Major Issues Report

Form 8-K - Current report